The Costs of Diabetes and Considerations for Policy Responses

By Benedic N. Ippolito

Joint Economic Committee

July 27, 2023


In my testimony, I will emphasize what we know about the costs of diabetes and, in turn, potential value stemming from relatively new therapies for the disease (and related conditions). I’ll conclude by emphasizing principles that can help guide policy aimed at alleviating both the health and non-health costs associated with this condition.

Read the full testimony here.

Sign up for Vital Signs

A monthly roundup of health policy research, reform proposals, and commentary by AEI Health scholars